Evaluating the Use of Thymoglobulin, Sirolimus, and Donor Bone Marrow With Kidney Transplantation Patients - Related Studies

Evaluating the Use of Thymoglobulin, Sirolimus, and Donor Bone Marrow With Kidney Transplantation Patients

This study has been completed.

Study NCT00062712. Last updated on March 23, 2007. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Kidney Transplantation

2	Additional drug interventions recognized in this trial
		Antilymphocyte Serum
		Sirolimus

3	More general drug interventions related to this trial
		Anti-Bacterial Agents
		Anti-Infective Agents
		Antibiotics, Antineoplastic
		Antifungal Agents
		Antineoplastic Agents
		Immunologic Factors
		Immunosuppressive Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

4	Sponsors listed in this trial
		National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)